0001209191-13-022280.txt : 20130423 0001209191-13-022280.hdr.sgml : 20130423 20130423163055 ACCESSION NUMBER: 0001209191-13-022280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130419 FILED AS OF DATE: 20130423 DATE AS OF CHANGE: 20130423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 13776835 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-04-19 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP & CFO Common Stock 2013-04-19 4 M 0 15858 51.75 A 46068 D Common Stock 2013-04-19 4 M 0 27187 38.80 A 73255 D Common Stock 2013-04-19 4 M 0 24921 33.82 A 98176 D Common Stock 2013-04-19 4 M 0 40781 39.05 A 138957 D Common Stock 2013-04-19 4 M 0 54375 33.55 A 193332 D Common Stock 2013-04-19 4 M 0 33983 33.28 A 227315 D Common Stock 2013-04-19 4 M 0 36250 35.35 A 263565 D Common Stock 2013-04-19 4 M 0 54375 36.30 A 317940 D Common Stock 2013-04-19 4 M 0 28570 28.84 A 346510 D Common Stock 2013-04-19 4 M 0 36250 32.16 A 382760 D Common Stock 2013-04-19 4 M 0 73500 35.64 A 456260 D Common Stock 2013-04-19 4 M 0 300000 33.00 A 756260 D Common Stock 2013-04-19 4 M 0 13593 37.86 A 769853 D Common Stock 2013-04-19 4 S 0 691318 81.50 D 78535 D Common Stock 2013-04-19 4 S 0 54367 85.00 D 24168 D Common Stock 5205 I 401(k) Employee Stock Option (right to buy) 35.64 2013-04-19 4 M 0 73500 0.00 D 2016-02-01 Common Stock 73500 0 D Employee Stock Option (right to buy) 35.35 2013-04-19 4 M 0 36250 0.00 D 2016-07-19 Common Stock 36250 0 D Employee Stock Option (right to buy) 36.30 2013-04-19 4 M 0 54375 0.00 D 2017-01-23 Common Stock 54375 0 D Employee Stock Option (right to buy) 28.84 2013-04-19 4 M 0 28570 0.00 D 2017-07-11 Common Stock 28570 0 D Employee Stock Option (right to buy) 32.16 2013-04-19 4 M 0 36250 0.00 D 2018-07-23 Common Stock 36250 0 D Employee Stock Option (right to buy) 33.55 2013-04-19 4 M 0 54375 0.00 D 2019-02-04 Common Stock 54375 0 D Employee Stock Option (right to buy) 33.28 2013-04-19 4 M 0 33983 0.00 D 2019-07-15 Common Stock 33983 2267 D Employee Stock Option (right to buy) 33.00 2013-04-19 4 M 0 300000 0.00 D 2019-10-21 Common Stock 300000 0 D Employee Stock Option (right to buy 39.05 2013-04-19 4 M 0 40781 0.00 D 2020-02-03 Common Stock 40781 13594 D Employee Stock Option (right to buy) 33.82 2013-04-19 4 M 0 24921 0.00 D 2020-07-13 Common Stock 24921 11329 D Employee Stock Option (right to buy) 38.80 2013-04-19 4 M 0 27187 0.00 D 2021-02-02 Common Stock 27187 27188 D Employee Stock Option (right to buy) 51.75 2013-04-19 4 M 0 15858 0.00 D 2021-07-12 Common Stock 15858 20392 D Employee Stock Option (right to buy) 37.86 2013-04-19 4 M 0 13593 0.00 D 2022-02-01 Common Stock 13593 40782 D Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. Fully vested. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/16/2009. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/04/2010. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/14/2010. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/03/2011. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/02/2012. Kenneth L. Horton, Attorney-In-Fact 2013-04-23